Bazsa, I had just finished reading this announcement from Novartis re: Phase 3 trial of Jakafi when your post appeared. I read all about its possible side effects.
https://www.novartis.com/news/media-releases/novartis-announces-phase-iii-study-jakavi-chronic-graft-versus-host-disease-met-primary-and-key-secondary-endpoints
Very interesting times ahead!
Bazsa, I had just finished reading this announcement from...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.14 |
Change
-0.043(3.60%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.18 | $1.14 | $1.680M | 1.460M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 86982 | $1.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.14 | 50145 | 20 |
View Market Depth
| Last trade - 11.02am 17/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |